| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/15/2000 | EP0985052A1 METHODS AND COMPOSITIONS TO IDENTIFY SWINE GENETICALLY RESISTANT TO F18 $i(E. COLI) ASSOCIATED DISEASES |
| 03/15/2000 | EP0985051A1 Nucleic acid probes for the detection and identification of fungi |
| 03/15/2000 | EP0985047A2 Somatic gene therapy to suppress secondary cataract formation |
| 03/15/2000 | EP0985046A1 A soluble vaccinia virus protein that binds chemokines |
| 03/15/2000 | EP0985045A2 Modulators of morphogen expression and methods of identifying the same |
| 03/15/2000 | EP0985042A1 Protease enzymes for tough cleaning and/or spot and film reduction and compositions incorporating same |
| 03/15/2000 | EP0985041A1 Process of producing transgenic plants in which flowering is inhibited, and dna sequences used in said process |
| 03/15/2000 | EP0985040A1 Preparation of glycosylated tumor necrosis factor |
| 03/15/2000 | EP0985039A2 Artificial antibody polypeptides |
| 03/15/2000 | EP0985038A1 Sodium channel receptor |
| 03/15/2000 | EP0985037A1 Human multiple endocrine neoplasia type 1 protein |
| 03/15/2000 | EP0985036A1 Zinc ring protein |
| 03/15/2000 | EP0985035A2 Dna methyltransferase genomic sequences and antisense oligonucleotides |
| 03/15/2000 | EP0985034A1 Methods of controlling beta dimer formation in hemoglobin |
| 03/15/2000 | EP0985033A2 Polyvalent and polyclonal libraries |
| 03/15/2000 | EP0985032A1 RIBOSOME COMPLEXES AS SELECTION PARTICLES FOR $i(IN VITRO) DISPLAY AND EVOLUTION OF PROTEINS |
| 03/15/2000 | EP0985031A1 A METHOD TO MAP AND ISOLATE REGIONS OF CHROMOSOMES THAT INTERACT OR ASSOCIATE FUNCTIONALLY WITHIN OR BETWEEN CHROMOSOMES $i(IN VIVO) |
| 03/15/2000 | EP0985030A2 New human ribonuclease |
| 03/15/2000 | EP0984987A2 A soluble laminin receptor precursor and methods to ihnibit its interactions |
| 03/15/2000 | EP0984986A2 Human type 3 ryanodine receptor protein and dna molecules coding therefor |
| 03/15/2000 | EP0984984A2 HUMAN PROTEINS HAVING TRANSMEMBRANE DOMAINS AND DNAs ENCODING THESE PROTEINS |
| 03/15/2000 | EP0984983A2 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and a kinase domain |
| 03/15/2000 | EP0984925A1 Compounds, preparation and use for transferring nucleic acids into cells |
| 03/15/2000 | EP0984833A1 Device for selectively filtering under reduced pressure and for vacuum drying sample liquids or drops of sample liquids as well as use of said device |
| 03/15/2000 | EP0984790A1 Herpes simplex virus vp22 vaccines and methods of use |
| 03/15/2000 | EP0842434B1 Method for the quantitative measurement of human acute phase serum amyloid a protein; recombinant protein; specific antibody |
| 03/15/2000 | EP0753063B1 Use of dna oligomers for inhibition of hiv by decreasing ribosomal frameshifting |
| 03/15/2000 | EP0741791B1 Cd 69 transcriptional regulatory elements |
| 03/15/2000 | EP0734441B1 Derivatives of tachyplesin having inhibitory activity towards plant pathogenic fungi |
| 03/15/2000 | EP0723453B1 Method of treating reproductive disorders |
| 03/15/2000 | EP0672186B1 Improved strand displacement assay and complex useful therefor |
| 03/15/2000 | EP0658205B1 Lipoprotein associated phospholipase a2, inhibitors thereof and use of the same in diagnosis and therapy |
| 03/15/2000 | EP0651812B1 Modular promoter construct |
| 03/15/2000 | EP0649468B1 Soluble cr1 derivatives |
| 03/15/2000 | EP0610286B1 Recombinant immunotoxins |
| 03/15/2000 | EP0586375B1 Detergent compositions containing substantially pure eg iii cellulase |
| 03/15/2000 | EP0563311B1 Improved vaccines |
| 03/15/2000 | EP0563103B1 Enzymes and enzymatic detergent compositions |
| 03/15/2000 | EP0551325B1 Method of testing for salmonella |
| 03/15/2000 | EP0541726B1 Growth factor compositions, preparation and use |
| 03/15/2000 | EP0434721B1 Viral nucleotide sequences |
| 03/15/2000 | CN1247569A Transgenic plants with modified sterol biosynthetic pathways |
| 03/15/2000 | CN1247568A Fibroblast growth factor homologs |
| 03/15/2000 | CN1247567A Tumor necrosis factor receptor alfa 6 and receptor beta 6 |
| 03/15/2000 | CN1247566A Novel peptide, novel DNA, and novel antibody |
| 03/15/2000 | CN1247565A Nucleic acid sequence encoding beta-C-4-oxygenase from haematococcus pluvialis for biosynthesis of astaxanthin |
| 03/15/2000 | CN1247473A Agent and method of treatment for diseases and conditions associated with respiratory ailments and lung inflammation |
| 03/15/2000 | CN1247231A Method for expressing foreign gene with plant as bioreactor |
| 03/15/2000 | CN1247230A Xylitol dehydrogenase of acetobacter and its gene |
| 03/15/2000 | CN1247229A Paddy rice group of preventing rice blast |
| 03/15/2000 | CN1247228A Human pluripotent leukosis cell differentiated correlative gene |
| 03/15/2000 | CN1247195A Thrombolytic fusion protein targeting thrombus |
| 03/15/2000 | CA2282138A1 Nucleic acid analysis using complete n-mer arrays |
| 03/14/2000 | US6037527 Genetically engineered dicot plant carries the gene coding a bacillus endotoxin which is toxic to larve upon digestion; pesticides |
| 03/14/2000 | US6037526 Method of inserting viral DNA into plant material |
| 03/14/2000 | US6037525 Preparing recombinant plant cells having more uniform expression of foreign genes; providing a cell, transforming the cell with a vector that has two genetically engineered terminals that control gene expression |
| 03/14/2000 | US6037524 S-adenosyl-L-homocystein hydrolase promoter |
| 03/14/2000 | US6037523 Nucleotide sequences which are regulatory sequences which control preferential expression of exogenous genes in plants; for tissue preferential expression of genes |
| 03/14/2000 | US6037522 Agrobacterium-mediated transformation of monocots |
| 03/14/2000 | US6037521 Transgenic mouse expressing an β-Amyloid transgene |
| 03/14/2000 | US6037465 Universal process for isolating and purifying nucleic acids from extremely small amounts of highly contaminated various starting materials |
| 03/14/2000 | US6037463 Ribozyme that cleaves mutant messenger ribonucleic acids associated with cancer; anticarcinogenic agents; antitumor agents |
| 03/14/2000 | US6037462 Nucleic acids sequences with somatic adjustments in the multiple tumor suppressor gene in human cancers; for diagnosis and treatment of human cancer; anticarciongenic agents; antitumor agents |
| 03/14/2000 | US6037461 FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same |
| 03/14/2000 | US6037456 Process for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 03/14/2000 | US6037450 Genetically engineered binding polypeptide where carboxy terminal cysteine is replaced or is not palmitoylated; for the diagnosis and treatment of inflammation and autoimmune diseases; antiinflammatory agents |
| 03/14/2000 | US6037448 Chimeric viral protein with human lymphocyte determinant; for vaccine development against infection |
| 03/14/2000 | US6037329 Compositions containing nucleic acids and ligands for therapeutic treatment |
| 03/14/2000 | US6037324 Madcam-1 (mucosal addressin cell adhesion molecule-1); useful in the treatment of inflammatory bowel diseases and other diseases involving leukocyte infiltration of the gastrointestinal tract or other mucosal tissues |
| 03/14/2000 | US6037322 Beneficial in preventing the local extension of the microvascular and macrovascular occluding arterial thrombus, thereby reducing the neurological deficit resulting from the stroke; administered by continuous infusion |
| 03/14/2000 | US6037321 Fusion proteins comprising vasoactive intestinal peptide or PACAP |
| 03/14/2000 | US6037320 Neurotrophic factor (NT-4) |
| 03/14/2000 | US6037177 Method for increasing the efficiency of recombinant AAV production |
| 03/14/2000 | US6037176 Nucleotide sequences that are suppressors of human cell adhesion molecule gene expression; anticarcinogenic agents, antiinflammatory agents |
| 03/14/2000 | US6037173 Nucleic acid molecule that codes a thyroid receptor binding protein; for diagnosis and treatment of diseases associated with defects in the function of thyroid binding protein; for detection of mudulators of protein function |
| 03/14/2000 | US6037172 Viral transfer plasmid coding heterologous genes |
| 03/14/2000 | US6037163 Human microfibril-associated glycoprotein 4 splice variant |
| 03/14/2000 | US6037162 Nucleotide sequences coding a region of a nucleic acid cleaving enzyme; to be used as rare cutters in vitro for mapping and sequencing and in vivo for gene therapy and against parasites |
| 03/14/2000 | US6037161 Aspergillus protein with hydrolase activity; for degrading plant cell wall polysaccharides in the food industry, primarily in fruit and vegetable processing and in the paper and pulp industry |
| 03/14/2000 | US6037159 Polynucleotide coding a protein with the enzymatic activity to transfer sulfate groups to an oligosaccharide |
| 03/14/2000 | US6037158 Lactobacillus alcohol dehydrogenase which reacts with acetophenone to form r-phenylethanol |
| 03/14/2000 | US6037156 Bacterial host that contains nucleotide sequence which code for proteins involved in the synthesis of an acidic molecule |
| 03/14/2000 | US6037154 Method of producing L-serine by fermentation |
| 03/14/2000 | US6037152 Method for reducing carryover contamination in an amplification procedure |
| 03/14/2000 | US6037150 Insect sequences for improving the efficiency of secretion of non-secreted proteins in eukaryotic cells |
| 03/14/2000 | US6037149 Nucleotide sequence coding human interleukin-9; for the diagnosis of sensitivity to allergy and asthma |
| 03/14/2000 | US6037147 Nucleotide sequence coding electron transfer protein |
| 03/14/2000 | US6037146 CDNA clone HE8CH90 that encodes a novel 7-transmembrane receptor |
| 03/14/2000 | US6037145 Synthesizing staphlococcus protease; transforming cells with an expression vector comprising a gene coding for fusion protein, culturing transformed cells to express an insoluble fusion protein, recovering polypeptide |
| 03/14/2000 | US6037143 Genetically engineered protein for the treament of diabetes, osteoporosis and endometriosis |
| 03/14/2000 | US6037142 Nucleotide sequences used to suppress cytosolic human gene product associated with gene transcription; antiinflammatory agents; anticarcinogenic agents |
| 03/14/2000 | US6037137 Fluorogenic peptides for the detection of protease activity |
| 03/14/2000 | US6037133 IκBEGFP constructs, cell lines and methods of use |
| 03/14/2000 | US6037131 Screening candidate compound for ability to alter transcription from gene promoter; providing recombinant cell, contacting cell with candidate compound, detecting expression pattern of reporter gene in the presence candidate compound |
| 03/14/2000 | US6037130 Fluorescently labeled hairpin forming oligonucleotide; for amplification and detection of specific nucleotide sequences |
| 03/14/2000 | US6037125 Disruption of the mammalian RAD51 protein and disruption of proteins that associate with mammalian RAD51 for hindering cell proliferation and/or viability of proliferating cells |
| 03/14/2000 | US6037119 Screening for modulators of enzyme activity; propagating cells transformed or transfected with nucleotide sequences coding guanosine monophosphate, preparing extracts, screening for modulators |
| 03/14/2000 | US6036959 HCMV/HSV fusion glycoproteins |
| 03/14/2000 | US6036954 Polypeptides with sequence |
| 03/14/2000 | US6036953 Dna encoding with escherichia coli and fusion polypeptides |